Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

EMA Warns PRIME Applicants Over Missing Pediatric Investigation Plans

This article was originally published in SRA

Executive Summary

Two thirds of the applications submitted for entry into the European Medicines Agency's new PRIME (priority medicines) scheme in the month after its launch were missing a pediatric investigation plan or a PIP waiver.

Advertisement
Advertisement
UsernamePublicRestriction

Register